From the FDA: Panel Recommends Approval of Drug for ALS

Journal of the American Osteopathic Association, The - United States
doi 10.7556/jaoa.1995.95.11.681c
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

American Osteopathic Association

Related search

From the FDA: New Class of Asthma Drug Receives Advisory Approval

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1995English

New FDA Drug Approval Policies and HIV Vaccine Development.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1990English

FDA Approval of New Drugs

JAMA - Journal of the American Medical Association
Medicine
2014English

FDA Approval of Obesity Drugs

JAMA - Journal of the American Medical Association
Medicine
2012English

From the FDA: Approval of Medical Devices to Be Accelerated

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1995English

Panel Recommends Mammograms Start at 50

Cancer Discovery
Oncology
2016English

From the FDA: Epilepsy Drug Approved

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1994English

FDA Drug Approval Summary: Alemtuzumab as Single-Agent Treatment for B-Cell Chronic Lymphocytic Leukemia

Oncologist
Cancer ResearchMedicineOncology
2008English

From the FDA: Mislabeling of Drug for Kaposi's Sarcoma Rectified

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy